BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production
Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology
Read moreCanada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology
Read moreSandusky, Ohio–(Newsfile Corp. – February 4, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today revealed plans to expand its
Read moreThe pandemic is a “humanitarian disaster,” as noted by CNN. And there’s no slowdown in sight. Fortunately, we may be
Read moreMibelle Biochemistry’s Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market Lauded by Frost & Sullivan Canada
Read more